Cargando…

Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head

Glucocorticoids inhibit angiogenesis in the femoral head, which fails to nourish the bone tissue and leads to osteonecrosis. Restoring angiogenesis is not only essential for vessel formation, but also crucial for osteogenesis. Poly ((L)-lactic acid) (PLLA) is commonly used in the bone tissue enginee...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Guiyu, Zhang, Pingxin, Huang, Jian, Yu, Yao, Yang, Fenghe, Zhao, Xueqian, Wang, Wei, Li, Dongyang, Sun, Song, Niu, Xufeng, Chai, Limin, Li, Jinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863477/
https://www.ncbi.nlm.nih.gov/pubmed/36662078
http://dx.doi.org/10.3390/jfb14010031
_version_ 1784875344052879360
author Feng, Guiyu
Zhang, Pingxin
Huang, Jian
Yu, Yao
Yang, Fenghe
Zhao, Xueqian
Wang, Wei
Li, Dongyang
Sun, Song
Niu, Xufeng
Chai, Limin
Li, Jinyu
author_facet Feng, Guiyu
Zhang, Pingxin
Huang, Jian
Yu, Yao
Yang, Fenghe
Zhao, Xueqian
Wang, Wei
Li, Dongyang
Sun, Song
Niu, Xufeng
Chai, Limin
Li, Jinyu
author_sort Feng, Guiyu
collection PubMed
description Glucocorticoids inhibit angiogenesis in the femoral head, which fails to nourish the bone tissue and leads to osteonecrosis. Restoring angiogenesis is not only essential for vessel formation, but also crucial for osteogenesis. Poly ((L)-lactic acid) (PLLA) is commonly used in the bone tissue engineering field. Panax notoginseng saponins (PNS) and osteopractic total flavone (OTF) promote angiogenesis and osteogenesis, respectively. We designed a sequentially releasing PLLA scaffold including PLLA loaded with OTF (inner layer) and PLLA loaded with PNS (outer layer). We assessed the osteogenic effect of angiogenesis in this scaffold by comparing it with the one-layered scaffold (PLLA embedded with OTF and PNS) in vivo. Results from the micro-CT showed that the data of bone mineral density (BMD), bone volume (BV), and percent bone volume (BV/TV) in the PO-PP group were significantly higher than those in the POP group (p < 0.01). Histological analyses show that the PO-PP scaffold exhibits better angiogenic and osteogenic effects compared with the one-layered scaffold. These might result from the different structures between them, where the sequential release of a bi-layer scaffold achieves the osteogenic effect of vascularization by initially releasing PNS in the outer layer. We further explored the possible mechanism by an immunohistochemistry analysis and an immunofluorescence assay. The results showed that the protein expressions of vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule-1(CD31) in the PO-PP scaffold were significantly higher than those in the POP scaffold (p < 0.01); the protein expressions of osteocalcin (OCN), osteopontin (OPN), and alkaline phosphatase (ALP) in the PO-PP scaffold were significantly higher than those in the POP scaffold (p < 0.05). Upregulating the expressions of angiogenic and osteogenic proteins might be the possible mechanism.
format Online
Article
Text
id pubmed-9863477
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98634772023-01-22 Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head Feng, Guiyu Zhang, Pingxin Huang, Jian Yu, Yao Yang, Fenghe Zhao, Xueqian Wang, Wei Li, Dongyang Sun, Song Niu, Xufeng Chai, Limin Li, Jinyu J Funct Biomater Article Glucocorticoids inhibit angiogenesis in the femoral head, which fails to nourish the bone tissue and leads to osteonecrosis. Restoring angiogenesis is not only essential for vessel formation, but also crucial for osteogenesis. Poly ((L)-lactic acid) (PLLA) is commonly used in the bone tissue engineering field. Panax notoginseng saponins (PNS) and osteopractic total flavone (OTF) promote angiogenesis and osteogenesis, respectively. We designed a sequentially releasing PLLA scaffold including PLLA loaded with OTF (inner layer) and PLLA loaded with PNS (outer layer). We assessed the osteogenic effect of angiogenesis in this scaffold by comparing it with the one-layered scaffold (PLLA embedded with OTF and PNS) in vivo. Results from the micro-CT showed that the data of bone mineral density (BMD), bone volume (BV), and percent bone volume (BV/TV) in the PO-PP group were significantly higher than those in the POP group (p < 0.01). Histological analyses show that the PO-PP scaffold exhibits better angiogenic and osteogenic effects compared with the one-layered scaffold. These might result from the different structures between them, where the sequential release of a bi-layer scaffold achieves the osteogenic effect of vascularization by initially releasing PNS in the outer layer. We further explored the possible mechanism by an immunohistochemistry analysis and an immunofluorescence assay. The results showed that the protein expressions of vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule-1(CD31) in the PO-PP scaffold were significantly higher than those in the POP scaffold (p < 0.01); the protein expressions of osteocalcin (OCN), osteopontin (OPN), and alkaline phosphatase (ALP) in the PO-PP scaffold were significantly higher than those in the POP scaffold (p < 0.05). Upregulating the expressions of angiogenic and osteogenic proteins might be the possible mechanism. MDPI 2023-01-04 /pmc/articles/PMC9863477/ /pubmed/36662078 http://dx.doi.org/10.3390/jfb14010031 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Feng, Guiyu
Zhang, Pingxin
Huang, Jian
Yu, Yao
Yang, Fenghe
Zhao, Xueqian
Wang, Wei
Li, Dongyang
Sun, Song
Niu, Xufeng
Chai, Limin
Li, Jinyu
Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head
title Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head
title_full Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head
title_fullStr Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head
title_full_unstemmed Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head
title_short Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head
title_sort sequential release of panax notoginseng saponins and osteopractic total flavone from poly ((l)-lactic acid) scaffold for treating glucocorticoid-associated osteonecrosis of femoral head
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863477/
https://www.ncbi.nlm.nih.gov/pubmed/36662078
http://dx.doi.org/10.3390/jfb14010031
work_keys_str_mv AT fengguiyu sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT zhangpingxin sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT huangjian sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT yuyao sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT yangfenghe sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT zhaoxueqian sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT wangwei sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT lidongyang sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT sunsong sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT niuxufeng sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT chailimin sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead
AT lijinyu sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead